83 related articles for article (PubMed ID: 19849807)
1. Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients.
Lau KK; Berg GM; Schjoneman YG; Perez RV; Butani L
Pediatr Transplant; 2010 Jun; 14(4):488-95. PubMed ID: 19849807
[TBL] [Abstract][Full Text] [Related]
2. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
[TBL] [Abstract][Full Text] [Related]
3. Rapid steroid discontinuation for pediatric renal transplantation: a single center experience.
Lau KK; Haddad MN; Berg GM; Perez RV; Butani L
Pediatr Transplant; 2007 Aug; 11(5):504-10. PubMed ID: 17631018
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of intensive initial immunosuppression protocol in pediatric deceased donor renal transplantation.
Olaitan OK; Zimmermann JA; Shields WP; Rodriguez-Navas G; Awan A; Mohan P; Little DM; Hickey DP
Pediatr Transplant; 2010 Feb; 14(1):87-92. PubMed ID: 19309452
[TBL] [Abstract][Full Text] [Related]
8. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
Roberti I; Reisman L; Lieberman KV; Burrows L
Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
[TBL] [Abstract][Full Text] [Related]
9. Steroid avoidance in renal transplantation.
Lightner A; Concepcion W; Grimm P
Curr Opin Organ Transplant; 2011 Oct; 16(5):477-82. PubMed ID: 21844809
[TBL] [Abstract][Full Text] [Related]
10. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
11. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
13. Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
Humar A; Dunn T; Kandaswamy R; Payne WD; Sutherland DE; Matas AJ
Clin Transpl; 2007; ():43-50. PubMed ID: 18637457
[TBL] [Abstract][Full Text] [Related]
14. Acute humoral rejection in pediatric renal transplant recipients receiving steroid minimization immunosuppression.
Butani L; Gallay BJ
Pediatr Transplant; 2012 May; 16(3):269-73. PubMed ID: 22093061
[TBL] [Abstract][Full Text] [Related]
15. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol.
Ibrahim H; Rogers T; Casingal V; Sturdevant M; Tan M; Humar A; Gillingham K; Matas A
Transplantation; 2006 Jan; 81(2):214-9. PubMed ID: 16436965
[TBL] [Abstract][Full Text] [Related]
16. Towards minimizing immunosuppression in pediatric liver transplant recipients.
Turmelle YP; Nadler ML; Anderson CD; Doyle MB; Lowell JA; Shepherd RW
Pediatr Transplant; 2009 Aug; 13(5):553-9. PubMed ID: 19067920
[TBL] [Abstract][Full Text] [Related]
17. Success of a steroid-minimization immunosuppression protocol for renal transplantation in the presence of donor-specific antibodies.
Butani L; Perez RV; Gallay BJ
Pediatr Transplant; 2009 Aug; 13(5):624-7. PubMed ID: 18992067
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
19. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
